In Wednesday's regular trading session, as of 12.00 pm, the following are the healthcare stocks that reached their 52 week high and 52 week low prices.
The 52-week High List
Array Biopharma Inc. (ARRY: Quote) recorded another new high of $5.83, and is currently trading at $5.66. The stock has gained 162% year-to-date. The company awaits five potential phase III decisions by the end of 2013.
Senior living facility operator Brookdale Senior Living Inc. (BKD: Quote) touched another new high of $21.70, and is currently trading at $21.62. The stock is up 24% year-to-date.
Capital Senior Living Corp. (CSU: Quote), an operator of senior living communities, hit another new high of $12.25, and is currently trading at $12.07. The stock has gained 52% year-to-date. So far this year, the company has acquired seven communities for a combined purchase price of $75.6 million, and is planning to meet or exceed this level of transactions in the second half of 2012.
Aesthetic medical device company Cynosure Inc. (CYNO: Quote) touched another new high of $27.15, and is currently trading at $27.11. The stock is up more than 130% year-to-date.
Emeritus Corp. (ESC: Quote), an operator of senior living communities, set a new high of $21, and is currently trading at $20.28. So far this year, the stock has gained nearly 16%. With very good expense controls, the company is confident of maintaining year-over-year revenue growth rate ahead of its expense growth rate, resulting in enhanced margins and cash flow over time.
Five Star Quality Care Inc. (FVE: Quote), a senior living and healthcare services provider, recorded a new high of $4.24, and is currently trading at $4.08. The stock is up 36% year-to-date.
Neogenomics Inc. (NGNM.OB), a provider of cancer-focused genetic testing services, rose to a new high of $2.75, and is currently trading at $2.70. The stock is up nearly 93% year-to-date. The company has launched 20 new molecular assays so far this year, and expects to launch another 15-20 assays, including the new NeoTYPE Cancer Profiles, by year-end.
Pharmacyclics Inc. (PCYC: Quote), a clinical-stage biopharmaceutical company, touched another new high of $64.05, and is currently trading at $64.02. The stock is up a whopping 332% year-to-date. The company has enrolled the fifth patient in the phase II trial, dubbed SPARK, of Ibrutinib in patients with relapsed or refractory mantle cell lymphoma, triggering a significant milestone payment from its partner Janssen Biotech Inc. This global study conducted by Janssen is planned to enroll 110 patients worldwide.
Sunrise Senior Living Inc. (SRZ: Quote), a provider of senior living services, recorded another new high of $14.30, and is currently trading at $14.26. The stock is up 120% year-to-date. Today, the company announced that it has agreed to be acquired by Health Care REIT (REIT for $14.50 a share.
The 52-week Low List
Advaxis Inc. (ADXS.OB), a biotechnology company focused on developing immunotherapies for cancer and infectious diseases, recorded a new low of $0.06. The stock is down over 60% year-to-date.
Affymetrix Inc. (AFFX: Quote), a medical equipment company, dropped to a new low of $3.64, and is currently trading at $3.65. The stock has lost 11% of its value year-to-date.
Medical device company Nxstage Medical Inc. (NXTM: Quote) recorded another new low of $12.23, and is currently trading at $12.33. The stock has lost nearly 31% of its value year-to-date. Earlier this month, the company reported a narrower loss on 10% revenue growth in Q2. However, the Q3 outlook provided is below analysts' estimates.
Oxygen Biotherapeutics Inc. (OXBT: Quote), a development stage biomedical company, slumped to a new low of $0.87, and is currently trading at $0.90. The stock is down 37% year-to-date.
Sagent Pharmaceuticals Inc. (SGNT: Quote) touched a new low of $12.66, and is currently trading at $12.78. So far this year, the stock has lost 39%.
 | | To receive FREE breaking news email alerts for Array BioPharma Inc. and others in your portfolio |
|
by RTT Staff Writer
For comments and feedback: editorial@rttnews.com
Business News